Skip to content

Targeted Medical Pharma, Inc.

CIK 0001420030

← back to feed
Revenue (TTM)
$5.65M
−26.0% YoY FY Apr 2016
Net Income (TTM)
−$3.48M
+21.9% YoY FY Apr 2016
EPS Diluted (TTM)
$0.11
−533.3% YoY FY Apr 2016
Gross Margin
63.2%
FY Apr 2016
Operating Margin
-41.6%
FY Apr 2016
Net Margin
-61.6%
FY Apr 2016
Free Cash Flow (TTM)
−$2.9M
FY Apr 2016
Cash
$82.64K
FY Apr 2016
Total Debt
—
FY Apr 2016
Shares Outstanding
30.19M sh
FY Apr 2016

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings